Gisele De Freitas Gauze

Dr. Gisele De Freitas Gauze


Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2021 in Bioorganic & Medicinal Chemistry
Verified
Journal Article
Closed access
DYDiego A.S. Yamazaki
Diego A.S. Yamazaki
ARAndrew M.F. Rozada
Andrew M.F. Rozada
PBPaula Baréa
Paula Baréa
ERElaine C. Reis
Elaine C. Reis
EBErnani A. Basso
Ernani A. Basso
GGGisele De Freitas Gauze
Gisele De Freitas Gauze


31 May 2019 in Future Microbiology
Verified
Journal Article
Closed access
ARAndrew Mf Rozada
Andrew Mf Rozada
FRFranciele Av Rodrigues
Franciele Av Rodrigues
ESEloísa G Sampiron
Eloísa G Sampiron
Flavio Augusto Vicente SeixasFlavio Augusto Vicente Seixas
Flavio Augusto Vicente Seixas
EBErnani A Basso
Ernani A Basso
GGGisele De Freitas Gauze
Gisele De Freitas Gauze
Aim: 17 new 4-methoxynaphthalene-N-acylhydrazones were synthesized in order to evaluate their biological action against important pathogens. Methods: In vitro susceptibility assays of compounds wer...

1 July 2020 in Bioorganic & Medicinal Chemistry Letters
Verified
Journal Article
Closed access
ARAndrew M.F. Rozada
Andrew M.F. Rozada
FRFranciele A.V. Rodrigues-Vendramini
Franciele A.V. Rodrigues-Vendramini
DGDavana S. Gonçalves
Davana S. Gonçalves
FRFernanda Rosa
Fernanda Rosa
EBErnani A. Basso
Ernani A. Basso
GGGisele De Freitas Gauze
Gisele De Freitas Gauze

1 September 2017 in Antimicrobial Agents and Chemotherapy
Verified
Journal Article
Closed access
PDF file
MBMariane C. Bagatin
Mariane C. Bagatin
APArethusa L. Pimentel
Arethusa L. Pimentel
DBDébora C. Biavatti
Débora C. Biavatti
EBErnani A. Basso
Ernani A. Basso
EKErika S. Kioshima
Erika S. Kioshima
GGGisele De Freitas Gauze
Gisele De Freitas Gauze
This work evaluated new potential inhibitors of the enzyme homoserine dehydrogenase (HSD) of Paracoccidioides brasiliensis , one of the etiological agents of paracoccidioidomycosis. The tertiary structure of the protein bonded to the analogue NAD, and l -homoserine was modeled by homology. The model with the best output was subjected to gradient minimization, redocking, and molecular dynamics simulation. Virtual screening simulations with 187,841 molecules purchasable from the Zinc database were performed. After the screenings, 14 molecules were selected and analyzed by the use of absorption, distribution, metabolism, excretion, and toxicity criteria, resulting in four compounds for in vitro assays. The molecules HS1 and HS2 were promising, exhibiting MICs of 64 and 32 μg · ml −1 , respectively, for the Pb18 isolate of P. brasilensis , 64 μg · ml −1 for two isolates of P. lutzii , and also synergy with itraconazole. The application of these molecules to human-pathogenic fungi confirmed that the HSD enzyme may be used as a target for the development of drugs with specific action against paracoccidioidomycosis; moreover, these compounds may serve as leads in the design of new antifungals.

13 January 2015 in Structural Chemistry
Verified
Journal Article
Closed access
PDF file
TRThiago C. Rozada
Thiago C. Rozada
MSMichael J. V. Da Silva
Michael J. V. Da Silva
DGDavana S. Gonçalves
Davana S. Gonçalves
MMMarcos Martins
Marcos Martins
RPRodrigo M. Pontes
Rodrigo M. Pontes
FRFernanda Rosa
Fernanda Rosa